Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases

被引:36
|
作者
Lee, Wang-Soo [1 ]
Ham, Woojin [2 ]
Kim, Jaetaek [2 ]
机构
[1] Chung Ang Univ, Div Cardiol, Dept Internal Med, Coll Med, Seoul 06974, South Korea
[2] Chung Ang Univ, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul 06974, South Korea
来源
LIFE-BASEL | 2021年 / 11卷 / 12期
基金
新加坡国家研究基金会;
关键词
NAD(P)H; quinone oxidoreductase 1; oxidative stress; human diseases; MEMBRANE REDOX SYSTEM; INDUCED DNA-DAMAGE; HIGH-FAT DIET; DT-DIAPHORASE; OXIDATIVE STRESS; NAD(P)H-QUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; BETA-LAPACHONE; PROTEASOMAL DEGRADATION; CRYSTAL-STRUCTURE;
D O I
10.3390/life11121301
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
NAD(P)H:quinone oxidoreductase (NQO) is an antioxidant flavoprotein that catalyzes the reduction of highly reactive quinone metabolites by employing NAD(P)H as an electron donor. There are two NQO enzymes-NQO1 and NQO2-in mammalian systems. In particular, NQO1 exerts many biological activities, including antioxidant activities, anti-inflammatory effects, and interactions with tumor suppressors. Moreover, several recent studies have revealed the promising roles of NQO1 in protecting against cardiovascular damage and related diseases, such as dyslipidemia, atherosclerosis, insulin resistance, and metabolic syndrome. In this review, we discuss recent developments in the molecular regulation and biochemical properties of NQO1, and describe the potential beneficial roles of NQO1 in diseases associated with oxidative stress.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
    Lee, Junguee
    Kim, Koon Soon
    Lee, Min Ho
    Kim, Yeon Soo
    Lee, Min Hee
    Lee, Seong Eun
    Kim, Yong Kyung
    Ryu, Min Jeong
    Kim, Soung Jung
    Choi, Min Jeong
    Jo, Young Suk
    YONSEI MEDICAL JOURNAL, 2013, 54 (05) : 1158 - 1167
  • [22] Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer
    Lewis, AM
    Ough, M
    Hinkhouse, MM
    Tsao, MS
    Oberley, LW
    Cullen, JJ
    MOLECULAR CARCINOGENESIS, 2005, 43 (04) : 215 - 224
  • [23] NAD(P)H: quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia
    Hori, H
    Ohmori, O
    Matsumoto, C
    Shinkai, T
    Nakamura, J
    PSYCHIATRY RESEARCH, 2003, 118 (03) : 235 - 239
  • [24] Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?
    Cao, Lei
    Chen, Yuanqin
    Xu, Shuangta
    Cheng, Hongwei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] A Review of the Effects of Flavonoids on NAD(P)H Quinone Oxidoreductase 1 Expression and Activity
    Froyen, Erik B.
    Barrantes, Gianluis Pimentel
    JOURNAL OF MEDICINAL FOOD, 2025,
  • [26] Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells
    Winski, SL
    Koutalos, Y
    Bentley, DL
    Ross, D
    CANCER RESEARCH, 2002, 62 (05) : 1420 - 1424
  • [27] NAD(P)H:quinone oxidoreductase 1 (NQO1):: Role as a superoxide scavenger
    Siegel, D
    Gustafson, D
    Dehn, D
    Boonchoong, P
    Han, JY
    Berliner, L
    Ross, D
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 : S14 - S14
  • [28] Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues
    Sieger, D
    Ross, D
    FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) : 246 - 253
  • [29] Update of the NAD(P)H:Quinone oxidoreductase (NQO) gene family
    Vasiliou V.
    Ross D.
    Nebert D.W.
    Human Genomics, 2 (5) : 329 - 335
  • [30] Molecular characterization of NAD(P)H:quinone oxidoreductase of tobacco leaves
    F. Sparia
    G. Tedeschi
    P. Pupillo
    P. Trost
    Protoplasma, 1998, 205 : 52 - 58